Novo's Ozempic, Wegovy Targeted for Medicare Price Cuts (1)

- Pfizer’s top-selling breast cancer drug Ibrance also on list
- Drugmakers plan to ask Trump administration to pause talks
The US plans to slash the price it pays for the
Novo’s treatments for obesity and diabetes headline the government’s
Read more...